bicuculline has been researched along with alprostadil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Ibrahim, N; Kabashima, N; Shibuya, I; Sutarmo, SV; Ueta, Y; Yamashita, H | 1 |
2 other study(ies) available for bicuculline and alprostadil
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Prostaglandin E2 inhibits spontaneous inhibitory postsynaptic currents in rat supraoptic neurones via presynaptic EP receptors.
Topics: Alprostadil; Animals; Bicuculline; Dinoprostone; Excitatory Postsynaptic Potentials; GABA Antagonists; Kynurenic Acid; Male; Models, Neurological; Neurons; Organophosphorus Compounds; Prostaglandins E, Synthetic; Rats; Rats, Wistar; Receptors, Prostaglandin E; Supraoptic Nucleus; Synapses | 1999 |